10/08/2026
Treating may require targeting more than a single pathway.
This review examines why -directed therapies have shown limited clinical success, identifies co-targeting partners that could improve treatment efficacy, and highlights combination strategies and -based delivery systems that may enable more precise, personalized therapies for EGFR-high TNBC. Agnieszka Robaszkiewicz International Students Office - University of Lodz
in : https://doi.org/10.1016/j.gendis.2025.102026